Lange P H
Department of Urology, University of Washington Medical Center, Seattle.
Urol Clin North Am. 1990 Nov;17(4):813-7.
The exact usefulness of prostate-specific antigen for staging before radical prostatectomy is still unclear. Perhaps the marker's most exciting feature is its value in detecting residual disease after radical prostatectomy. The author also discusses the technical questions in testing and interpretation.
前列腺特异性抗原在根治性前列腺切除术之前进行分期的确切效用仍不明确。或许该标志物最令人兴奋的特性在于其在检测根治性前列腺切除术后残留疾病方面的价值。作者还讨论了检测及解读过程中的技术问题。